Historique
Mots-clès : FENTANYL
Documents disponibles dans cette catégorie (246)
Ajouter le résultat à votre sélection Affiner la recherche
Flyer (Le), n°64 - Septembre 2016
2016
Bulletin : Périodique
Drug Testing and Analysis, Vol.14, n°8 - August 2022
2022
Bulletin : Périodique
Drug Testing and Analysis, Vol.10, n°9 - September 2018
2018
Bulletin : Périodique
Journal of Analytical Toxicology, Vol.48, n°2 - March 2024
2024
Bulletin : PériodiqueNouveauté
Journal of Analytical Toxicology, Vol.48, n°3 - April 2024
2024
Bulletin : Périodique
Drug Testing and Analysis, Vol.10, n°8 - August 2018
2018
Bulletin : Périodique
Toxicologie Analytique et Clinique, Vol.30, n°4 - Décembre 2018
2018
Bulletin : Périodique
The 2017 National Drug Threat Assessment (NDTA) outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. Over the past 10 years, the drug landscape in the United States has s[...]
The National Drug Threat Assessment outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. Among the key 2018 NDTA findings: Controlled prescription drugs remain respo[...]
The 2019 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of both licit and illicit drugs. Illicit drugs, and [...]
The 2020 National Drug Threat Assessment (NDTA) is a comprehensive assessment of the threat posed to the United States by the trafficking and abuse of illicit drugs, the diversion and abuse of licit drugs, and the laundering of proceeds generate[...]![4F-iBF. Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF) in the framework of the Council Decision on new psychoactive substances](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_80448.webp)
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]
K. KUCZYNSKA ; P. GRZONKOWSKI ; L. KACPRZAK ; J. B. ZAWILSKA | 2018
Dans Forensic Science International (Vol.289, August 2018) Article : PériodiqueFentanyl is a potent synthetic opioid used as a narcotic analgesic supplement in general and regional anesthesia as well as in management of persistent, severe chronic pain. Alarming epidemiological and forensic medicine reports, accumulated mai[...]
This publication presents the data and findings of the risk assessment on N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of th[...]
K. M. WAYE ; J. L. YEDINAK ; J. KOZIOL ; B. D. L. MARSHALL | 2018
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : PériodiqueBackground: In 2015, the state of Rhode Island reported the fifth highest drug overdose mortality rate in the United States. In response to this crisis, Rhode Island created a statewide, publicly accessible drug surveillance and information syst[...]
